Payden & Rygel Cvs Health Corp Transaction History

Payden & Rygel

$1.3 Billion
Q3 2024

A detailed history of Payden & Rygel transactions in Cvs Health Corp stock. As of the latest transaction made, Payden & Rygel holds 99,900 shares of CVS stock, worth $4.66 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

99,900

Holding current value

$4.66 Million

% of portfolio

0.48%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$55.81 - $63.18 $5.58 Million - $6.31 Million	99,900 New	99,900 $6.28 Million
Q2 2024 Oct 07, 2024	SELL	$53.63 - $79.56 $15.2 Million - $22.5 Million	-283,400 Closed	0 $0
Q1 2024 Oct 08, 2024	BUY	$71.99 - $81.42 $13.2 Million - $14.9 Million	183,500 New	183,500 $14.6 Million
Q4 2023 Feb 12, 2024	BUY	$66.29 - $79.0 $14.4 Million - $17.2 Million	217,600 Added 214.6%	319,000 $25.2 Million
Q3 2023 Oct 07, 2024	SELL	$65.17 - $76.41 $2.32 Million - $2.72 Million	-35,600 Reduced 11.16%	283,400 $19.8 Million
Q2 2023 Aug 10, 2023	BUY	$66.65 - $77.75 $6.49 Million - $7.57 Million	97,300 Added 2373.17%	101,400 $7.01 Million
Q1 2023 May 10, 2023	SELL	$72.37 - $92.89 $31.3 Million - $40.1 Million	-432,100 Reduced 99.06%	4,100 $305,000
Q4 2022 Feb 13, 2023	BUY	$88.25 - $103.78 $2.56 Million - $3.01 Million	29,000 Added 7.12%	436,200 $40.6 Million
Q3 2022 Nov 10, 2022	BUY	$92.53 - $106.43 $805,011 - $925,941	8,700 Added 2.18%	407,200 $38.8 Million
Q2 2022 Aug 12, 2022	BUY	$88.66 - $106.64 $72,789 - $87,551	821 Added 0.21%	398,500 $36.9 Million
Q1 2022 Apr 13, 2022	SELL	$100.77 - $110.83 $11.6 Million - $12.7 Million	-114,700 Reduced 22.39%	397,679 $40.2 Million
Q4 2021 Feb 11, 2022	SELL	$83.15 - $103.7 $182,930 - $228,140	-2,200 Reduced 0.43%	512,379 $52.9 Million
Q3 2021 Nov 15, 2021	BUY	$80.05 - $87.47 $18.8 Million - $20.6 Million	235,300 Added 84.25%	514,579 $43.7 Million
Q2 2021 Aug 06, 2021	SELL	$73.79 - $89.81 $10.9 Million - $13.3 Million	-147,837 Reduced 34.61%	279,279 $23.3 Million
Q1 2021 May 13, 2021	BUY	$68.13 - $76.3 $1.14 Million - $1.28 Million	16,716 Added 4.07%	427,116 $32.1 Million
Q4 2020 Feb 08, 2021	BUY	$55.93 - $74.5 $7.16 Million - $9.54 Million	128,100 Added 45.38%	410,400 $28 Million
Q3 2020 Nov 10, 2020	SELL	$56.71 - $65.71 $4.34 Million - $5.03 Million	-76,600 Reduced 21.34%	282,300 $16.5 Million
Q2 2020 Aug 12, 2020	SELL	$55.41 - $70.62 $60,950 - $77,682	-1,100 Reduced 0.31%	358,900 $23.3 Million
Q1 2020 May 04, 2020	BUY	$52.3 - $76.05 $798,673 - $1.16 Million	15,271 Added 4.43%	360,000 $21.4 Million
Q4 2019 Jan 31, 2020	SELL	$60.38 - $76.58 $15.1 Million - $19.2 Million	-250,200 Reduced 42.06%	344,729 $25.6 Million
Q3 2019 Oct 30, 2019	BUY	$54.09 - $64.3 $5.85 Million - $6.95 Million	108,129 Added 22.21%	594,929 $37.5 Million
Q2 2019 Aug 06, 2019	BUY	$52.13 - $57.33 $12 Million - $13.2 Million	229,800 Added 89.42%	486,800 $26.5 Million
Q1 2019 May 08, 2019	BUY	$52.36 - $69.88 $13.5 Million - $18 Million	257,000 New	257,000 $13.9 Million

Others Institutions Holding CVS

# of Institutions

2,110

Shares Held

975M

Call Options Held

24.9M

Put Options Held

20.2M

View Full List

About CVS HEALTH Corp

Ticker CVS
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 1,312,829,952
Market Cap $61.2B
Description
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governme...

More about CVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.

Account